{"id":26453,"date":"2014-06-19T09:53:10","date_gmt":"2014-06-19T13:53:10","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=26453"},"modified":"2014-06-19T09:53:10","modified_gmt":"2014-06-19T13:53:10","slug":"biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453","title":{"rendered":"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/19\/2014 (wallstreetpr) \u2013\u00a0One of the leading specialty pharmaceutical companies,<b> BioDelivery Sciences International, Inc. (NASDAQ:BDSI) <\/b>is making its mark in the<b> <\/b>delivery technologies pertaining to patented drugs.<b> <\/b>The company has launched a series of innovational and highly commercial technologies for other companies and consumers in the field of therapeutics. BDSI is also evolving new methods and services to reach to patient\u2019s unmet needs and create a revolution in the medical field. It has expanded its spectrum from low to chronic diseases and is strategizing to achieve best results. In furtherance of the same, it has also participated in a series of conferences.<\/p>\n<p style=\"text-align: justify;\"><b>Participation in Conferences<\/b><\/p>\n<p style=\"text-align: justify;\">BioDelivery Sciences International, Inc. (NASDAQ:BDSI)\u00a0has recently participated in two of the most strategic conferences to shape and shape its strategies for coming quarters. The company participated in the Annual William Blair Growth Stock Conference that took place on June 11, 2014. The company has recently received approval from FDA with regard to its New Drug Application for BUNAVAIL\u2122. The company made representations pertaining to the usage and effect pertaining to the approval. The company also revealed the commercial viability and market opportunity.<\/p>\n<p style=\"text-align: justify;\">It has also participated in the Wells Fargo 2014 Healthcare Conference that took place on June 17, 2014. BDSI made presentations pertaining to its ongoing Phase 3 program related to BEMA Buprenorphine and multiple other potential projects and products of the company. Thus, BioDelivery Sciences International, Inc. (NASDAQ:BDSI)\u00a0is moving towards aligning its strategies with its goals of the coming quarters.<\/p>\n<p style=\"text-align: justify;\"><b>FDA Approval <\/b><\/p>\n<p style=\"text-align: justify;\">BioDelivery Sciences International, Inc. (NASDAQ:BDSI)\u00a0recently announced that it has been granted approval by FDA with regard to the New Drug Application for BUNAVAIL\u2122. It is recognized towards treatment of opoid dependence. The company is targeting the inclusion of the new application in the complete treatment plan of the patients. The company has further announced to launch BUNAVAIL by the end of its third quarter of this year. it is efficient as compared to the previously present Suboxone in the market has comparatively lesser side-effects.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/19\/2014 (wallstreetpr) \u2013\u00a0One of the leading specialty pharmaceutical companies, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is making its mark in the delivery technologies pertaining [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":26454,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7461,7462],"stock_ticker":[],"class_list":["post-26453","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-biodelivery-sciences-international-inc-nasdaqbdsi","tag-nasdaqbdsi","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/19\/2014 (wallstreetpr) \u2013\u00a0One of the leading specialty pharmaceutical companies, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is making its mark in the delivery technologies pertaining [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-19T13:53:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"255\" \/>\n\t<meta property=\"og:image:height\" content=\"197\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes\",\"datePublished\":\"2014-06-19T13:53:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\"},\"wordCount\":345,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg\",\"keywords\":[\"BioDelivery Sciences International Inc. (NASDAQ:BDSI)\",\"NASDAQ:BDSI\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\",\"name\":\"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg\",\"datePublished\":\"2014-06-19T13:53:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg\",\"width\":255,\"height\":197},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453","og_locale":"en_US","og_type":"article","og_title":"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes - Wall Street PR","og_description":"Boston, MA 06\/19\/2014 (wallstreetpr) \u2013\u00a0One of the leading specialty pharmaceutical companies, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is making its mark in the delivery technologies pertaining [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-06-19T13:53:10+00:00","og_image":[{"width":255,"height":197,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes","datePublished":"2014-06-19T13:53:10+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453"},"wordCount":345,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg","keywords":["BioDelivery Sciences International Inc. (NASDAQ:BDSI)","NASDAQ:BDSI"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453","url":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453","name":"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg","datePublished":"2014-06-19T13:53:10+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/BioDelivery-Sciences-International-Inc..jpg","width":255,"height":197},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/biodelivery-sciences-international-inc-nasdaqbdsi-fda-approval-lifts-hopes-26453#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"BioDelivery Sciences International, Inc. (NASDAQ:BDSI): FDA Approval Lifts Hopes"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/26453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=26453"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/26453\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/26454"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=26453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=26453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=26453"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=26453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}